Highlights and Quick Summary
- Net Income Common for the quarter ending September 30, 2023 was $-50.7 Million (a 19.64% increase compared to previous quarter)
- Year-over-year quarterly Net Income Common increased by 24.91%
- Annual Net Income Common for 2022 was $-142 Million (a -22.87% decrease from previous year)
- Annual Net Income Common for 2021 was $-184 Million (a 3542.31% increase from previous year)
- Annual Net Income Common for 2020 was $-5.06 Million (a 80.92% increase from previous year)
- Twelve month Net Income Common ending September 30, 2023 was $-173 Million (a 9.49% increase compared to previous quarter)
- Twelve month trailing Net Income Common increased by 21.88% year-over-year
Trailing Net Income Common for the last four month:
| 30 Sep '23 | 30 Jun '23 | 31 Mar '23 | 31 Dec '22 |
|---|---|---|---|
| $-173 Million | $-158 Million | $-151 Million | $-142 Million |
Visit stockrow.com/PRME
for comprehensive keystats, realtime prices, income statement, balance sheet, cash flow
statement with 10 years of data, and state-of-the-art screener.
Historical Net Income Common of Prime Medicine, Inc.
Most recent Net Income Commonof PRME including historical data for past 10 years.Interactive Chart of Net Income Common of Prime Medicine, Inc.
Prime Medicine, Inc. Net Income Common for the past 10 Years (both Annual and Quarterly)
(All values are in $ million)
| Year | Q1 | Q2 | Q3 | Q4 | Fiscal Year |
|---|---|---|---|---|---|
| 2023 | $-50.71 | $-42.39 | $-39.4 | – | – |
| 2022 | $-40.6 | $-35.71 | $-35.64 | $-30.06 | $-142.01 |
| 2021 | – | – | – | $-22.78 | $-184.12 |
| 2020 | – | – | – | – | $-5.06 |
| 2019 | – | – | – | – | $-2.79 |
Business Profile of Prime Medicine, Inc.
Sector: Healthcare
Industry: Biotechnology